BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32399781)

  • 1. Patterns of care and cost profiles of women with breast cancer in Italy: EPICOST study based on real world data.
    Francisci S; Guzzinati S; Capodaglio G; Pierannunzio D; Mallone S; Tavilla A; Lopez T; Busco S; Mazzucco W; Angiolini C; Zorzi M; Serraino D; Barchielli A; Fusco M; Stracci F; Bianconi F; Rugge M; Iacovacci S; Russo AG; Cusimano R; Gigli A
    Eur J Health Econ; 2020 Sep; 21(7):1003-1013. PubMed ID: 32399781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The challenge of sustainability in healthcare systems: Frequency and cost of inappropriate patterns of breast cancer care (the E.Pic.A study).
    Massa I; Balzi W; Burattini C; Gentili N; Bucchi L; Nanni O; Gallegati D; Pierini A; Amadori D; Falcini F; Altini M
    Breast; 2017 Aug; 34():103-107. PubMed ID: 28558338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of breast cancer based on real-world data: a cancer registry study in Italy.
    Capri S; Russo A
    BMC Health Serv Res; 2017 Jan; 17(1):84. PubMed ID: 28122558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost profiles of colorectal cancer patients in Italy based on individual patterns of care.
    Francisci S; Guzzinati S; Mezzetti M; Crocetti E; Giusti F; Miccinesi G; Paci E; Angiolini C; Gigli A
    BMC Cancer; 2013 Jul; 13():329. PubMed ID: 23826976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical costs associated with metastatic breast cancer in younger, midlife, and older women.
    Trogdon JG; Baggett CD; Gogate A; Reeder-Hayes KE; Rotter J; Zhou X; Ekwueme DU; Fairley TL; Wheeler SB
    Breast Cancer Res Treat; 2020 Jun; 181(3):653-665. PubMed ID: 32346820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Economic Impact of Rectal Cancer: A Population-Based Study in Italy.
    Gigli A; Francisci S; Capodaglio G; Pierannunzio D; Mallone S; Tavilla A; Lopez T; Zorzi M; Stracci F; Busco S; Mazzucco W; Lonardi S; Bianconi F; Russo AG; Iacovacci S; Serraino D; Manneschi G; Fusco M; Cusimano R; Rugge M; Guzzinati S
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33430156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
    Sagar B; Lin YS; Castel LD
    J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States.
    Fu AZ; Jhaveri M
    J Med Econ; 2012; 15(4):688-94. PubMed ID: 22397589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs for Breast Cancer Care in the Military Health System: An Analysis by Benefit Type and Care Source.
    Eaglehouse YL; Manjelievskaia J; Shao S; Brown D; Hofmann K; Richard P; Shriver CD; Zhu K
    Mil Med; 2018 Nov; 183(11-12):e500-e508. PubMed ID: 29660010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France.
    Mounié M; Costa N; Conte C; Petiot D; Fabre D; Despas F; Lapeyre-Mestre M; Laurent G; Savy N; Molinier L
    J Med Econ; 2020 Mar; 23(3):235-242. PubMed ID: 31876205
    [No Abstract]   [Full Text] [Related]  

  • 11. Current treatment patterns and medical costs for multiple myeloma in Japan: a cross-sectional analysis of a health insurance claims database.
    Uno S; Goto R; Suzuki K; Iwasaki K; Takeshima T; Ohtsu T
    J Med Econ; 2020 Feb; 23(2):166-173. PubMed ID: 31682533
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer cost profiles: The Epicost estimation approach.
    Francisci S; Capodaglio G; Gigli A; Mollica C; Guzzinati S
    Front Public Health; 2022; 10():974505. PubMed ID: 36211660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2- metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysis.
    Li N; Hao Y; Koo V; Fang A; Peeples M; Kageleiry A; Wu EQ; Guérin A
    J Med Econ; 2016; 19(4):414-23. PubMed ID: 27032967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administrative and claims records as sources of health care cost data.
    Riley GF
    Med Care; 2009 Jul; 47(7 Suppl 1):S51-5. PubMed ID: 19536019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HR+/HER2- Metastatic Breast Cancer: Epidemiology, Prescription Patterns, Healthcare Resource Utilisation and Costs from a Large Italian Real-World Database.
    Piccinni C; Dondi L; Ronconi G; Calabria S; Pedrini A; Esposito I; Martini N; Marangolo M
    Clin Drug Investig; 2019 Oct; 39(10):945-951. PubMed ID: 31347036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States.
    Kariburyo F; Xie L; Sah J; Li N; Lofland JH
    J Med Econ; 2020 Jan; 23(1):1-9. PubMed ID: 31589081
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden of diverticular disease: An observational analysis based on real world data from an Italian region.
    Mennini FS; Sciattella P; Marcellusi A; Toraldo B; Koch M
    Dig Liver Dis; 2017 Sep; 49(9):1003-1008. PubMed ID: 28663067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.